ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
32 hedge funds and large institutions have $18M invested in Acorda Therapeutics in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
61% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 23
Holders
32
Holding in Top 10
–
Calls
$1.19M
Puts
$924K
Top Buyers
| 1 | +$3.61M | |
| 2 | +$956K | |
| 3 | +$650K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$337K |
| 5 |
CCM
Chilton Capital Management
Houston,
Texas
|
+$311K |
Top Sellers
| 1 | -$151K | |
| 2 | -$81K | |
| 3 | -$53K | |
| 4 |
Squarepoint
New York
|
-$42K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$35K |